Deka Bank Deutsche Girozentrale Vertex Pharmaceuticals Inc Transaction History
Deka Bank Deutsche Girozentrale
- $54.1 Billion
- Q4 2024
A detailed history of Deka Bank Deutsche Girozentrale transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 506,457 shares of VRTX stock, worth $238 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
506,457
Previous 506,457
-0.0%
Holding current value
$238 Million
Previous $233 Million
12.15%
% of portfolio
0.38%
Previous 0.43%
Shares
28 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
222MCall Options Held
1.65MPut Options Held
1.37M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.55 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.23 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...